M1 Kliniken AG/€M12
05:30
09:10
12:45
16:25
20:00
1D1W1MYTD1Y5YMAX
About M1 Kliniken AG
M1 Kliniken AG, headquartered in Berlin, Germany, specializes in aesthetic medicine and plastic surgery services. Operating under the "M1 Med Beauty" brand, the company offers treatments such as breast augmentation, eyelid lifts, liposuction, and non-invasive procedures like hyaluronic acid and botulinum toxin injections. As of 2023, M1 Kliniken operates 58 specialist centers across ten countries, including Germany, Austria, the Netherlands, Switzerland, the United Kingdom, Croatia, Hungary, Bulgaria, Romania, and Australia. The company also manages the M1 Schlossklinik in Berlin, a facility with six operating theaters and 35 beds. M1 Kliniken's strategic focus on specialization and centralized purchasing enables it to offer high-quality medical services at competitive prices.
Ticker
€M12
Sector
Primary listing
XETRA
Employees
280
Headquarters
Website
M1 Kliniken AG Metrics
BasicAdvanced
€341m
15.34
€1.19
1.07
€0.50
2.73%
Price and volume
Market cap
€341m
Beta
1.07
52-week high
€19.76
52-week low
€12.64
Average daily volume
3.4k
Dividend rate
€0.50
Financial strength
Current ratio
2.82
Quick ratio
1.601
Long term debt to equity
3.365
Total debt to equity
6.837
Dividend payout ratio (TTM)
42.06%
Interest coverage (TTM)
22.21%
Profitability
EBITDA (TTM)
35.376
Gross margin (TTM)
14.53%
Net profit margin (TTM)
6.08%
Operating margin (TTM)
9.38%
Effective tax rate (TTM)
29.25%
Revenue per employee (TTM)
€1,300,000
Management effectiveness
Return on assets (TTM)
11.33%
Return on equity (TTM)
16.96%
Valuation
Price to earnings (TTM)
15.342
Price to revenue (TTM)
0.932
Price to book
2.86
Price to tangible book (TTM)
11.31
Price to free cash flow (TTM)
8.944
Free cash flow yield (TTM)
11.18%
Free cash flow per share (TTM)
2.046
Dividend yield (TTM)
2.73%
Forward dividend yield
2.73%
Growth
Revenue change (TTM)
7.40%
Earnings per share change (TTM)
38.17%
3-year revenue growth (CAGR)
8.49%
10-year revenue growth (CAGR)
26.42%
3-year earnings per share growth (CAGR)
71.68%
10-year earnings per share growth (CAGR)
10.44%
10-year dividend per share growth (CAGR)
14.87%
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Market data provided by CBOE Europe and Deutsche Börse.
FAQs